These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2721203)

  • 1. Cardiac rhythm disorders in various types of hypertrophic cardiomyopathies.
    Gregor P; Widimský P; Kohout P; Sochor K; Bufka V; Cervenka V; Vísek V
    Cor Vasa; 1989; 31(1):16-24. PubMed ID: 2721203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relation between disorders of cardiac rhythm to the symptomatology and extent of hypertrophic cardiomyopathy].
    Gregor P; Widimský P; Kohout P; Sochor K; Bufka V; Cervenka V; Vísek V
    Vnitr Lek; 1989 Jul; 35(7):632-8. PubMed ID: 2800367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders of heart rhythm in hypertrophic cardiomyopathy].
    Gregor P; Widimský P; Kohout P; Sochor K; Bufka V; Cervenka V; Vísek V
    Vnitr Lek; 1989 Jul; 35(7):625-31. PubMed ID: 2800366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-duration electrocardiographic recording in 33 patients with obstructive cardiomyopathy].
    Baille N; Aliot E; Perrot B; Ethévenot G; Neimann JL; Godenir JP; Gilgenkrantz JM; Faivre G
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):730-7. PubMed ID: 6433835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart rhythm disorder in congestive cardiomyopathy (data from ECG at rest and from daily ECG monitoring)].
    Riabykina GV; Dauletbaeva SM; Vangeli RS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):30-5. PubMed ID: 6182892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrophic myocardiopathy (II). 24-hour electrocardiographic monitoring and its relation to the echocardiographic characteristics].
    de la Morena Valenzuela G; Ruipérez Abizanda JA; Picó Aracil F; Ruiz Ros JA; Campos Peris JV; Sánchez Muñoz JJ
    Rev Esp Cardiol; 1991 Mar; 44(3):168-73. PubMed ID: 2047547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
    Andriushchenko OM; Olesin AI
    Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of heart rhythm and conduction in dilated and hypertrophic cardiomyopathies].
    Vangeli RS; Naumov VG; Grigor'iants RA; Shevliagin SA; al-Shaer A
    Ter Arkh; 1985; 57(4):57-9. PubMed ID: 4040273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
    Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
    Wang Y; Cui YH; Wang DW
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):401-4. PubMed ID: 15061995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
    Hosokawa Y; Takano H; Ohno T; Takayama M; Takano T
    Angiology; 2008; 59(3):329-34. PubMed ID: 18388103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of transesophageal programmed atrial stimulation in the evaluation of unexplained cerebrovascular accidents].
    Brembilla-Perrot B; Blangy H; Holban I; Houriez P; Claudon O; Rizk J; Mauferon JB; Clavel A
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):103-8. PubMed ID: 12555333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical findings in hypertrophic cardiomyopathy and their relationship to the disease severity.
    Gregor P; Herold M; Widimský P; Cervenka V; Vísek V
    Czech Med; 1988; 11(2):94-100. PubMed ID: 3137009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sudden death risk factors in patients with hypertrophic cardiomyopathy].
    Dabrowski M; Borowiecka E; Michalak E; Rydlewska-Sadowska W; Ruzyłło W
    Kardiol Pol; 1989; 32(2):57-65. PubMed ID: 2482379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment.
    Williams L; Frenneaux M
    Europace; 2007 Sep; 9(9):817-22. PubMed ID: 17522079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ambulatory ECG in cardiomyopathies].
    Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.